Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

Collaborative Group on Hormonal Factors in Breast Cancer, R. Alexandra Goldbohm, Piet van den Brandt

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1159-1168
Number of pages10
JournalLancet
Volume394
Issue number10204
DOIs
Publication statusPublished - 28 Sep 2019

Keywords

  • INITIATIVE CLINICAL-TRIAL
  • ESTROGEN-PLUS-PROGESTIN
  • POSTMENOPAUSAL WOMEN

Cite this